LB Pharmaceuticals Inc
LBRX
$14.90
-$0.61-3.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.23M | 14.23M | 28.00M | 28.00M | 72.13M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 556.00K | 556.00K | 880.00K | 880.00K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.78M | 14.78M | 28.88M | 28.88M | -- |
|
|
|||||
| Total Current Assets | 14.78M | 14.78M | 28.88M | 28.88M | -- |
| Net Property, Plant & Equipment | 3.96M | 3.96M | 4.16M | 4.16M | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 508.00K | 508.00K | 498.00K | 498.00K | -- |
| Total Assets | 19.25M | 19.25M | 33.53M | 33.53M | -- |
|
|
|||||
| Total Accounts Payable | 635.00K | 635.00K | 2.32M | 2.32M | -- |
| Total Accrued Expenses | 2.54M | 2.54M | 5.30M | 5.30M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 730.00K | 730.00K | 487.00K | 487.00K | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.91M | 3.91M | 8.11M | 8.11M | -- |
|
|
|||||
| Total Current Liabilities | 3.91M | 3.91M | 8.11M | 8.11M | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.03M | 3.03M | 3.22M | 3.22M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.93M | 1.93M | 2.50M | 2.50M | -- |
| Total Liabilities | 8.86M | 8.86M | 13.83M | 13.83M | -- |
|
|
|||||
| Common Stock & APIC | 10.63M | 10.63M | 9.66M | 9.66M | -- |
| Retained Earnings | -114.50M | -114.50M | -104.32M | -104.32M | -- |
| Treasury Stock & Other | -- | -- | 111.00K | 111.00K | -- |
| Total Common Equity | -103.87M | -103.87M | -94.55M | -94.55M | -50.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 114.26M | 114.26M | 114.26M | 114.26M | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 114.26M | 114.26M | 114.26M | 114.26M | 114.26M |
|
|
|||||
| Total Common Equity | -103.87M | -103.87M | -94.55M | -94.55M | -50.45M |
| Total Preferred Equity | 114.26M | 114.26M | 114.26M | 114.26M | 114.26M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.39M | 10.39M | 19.71M | 19.71M | 63.81M |
|
|
|||||